Reaction
Joint Sprain reporting signals
As of the last recalculation, Joint Sprain appears in 1,046 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE (PRR 26.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amlodipine Besylate And Benazepril Hydrochloride | 12 | 26.1 | 26.2 |
| Carisoprodol | 20 | 21.2 | 21.3 |
| Tolterodine Tartrate | 8 | 17.9 | 17.9 |
| Raloxifene Hydrochloride | 12 | 16.5 | 16.5 |
| Ziprasidone Mesylate | 11 | 15.5 | 15.5 |
| Gemfibrozil | 11 | 14.6 | 14.6 |
| Interferon Beta-1B | 12 | 12.6 | 12.6 |
| Ziprasidone | 11 | 12.5 | 12.6 |
| Pioglitazone | 24 | 11.3 | 11.3 |
| Metformin Hcl | 30 | 11.1 | 11.1 |
| Conjugated Estrogens | 31 | 10.9 | 10.9 |
| Estrogens, Conjugated | 31 | 10.7 | 10.7 |
| Interferon Beta-1A | 94 | 10.5 | 10.5 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 11 | 9.4 | 9.4 |
| Natalizumab | 70 | 8.1 | 8.1 |
| Teriparatide | 43 | 7.9 | 7.9 |
| Exenatide | 19 | 7.3 | 7.3 |
| Orlistat | 8 | 6.2 | 6.2 |
| Hydrocodone Bitartrate | 9 | 4.1 | 4.2 |